PIK3CA and acute lymphoblastic leukemia: This study demonstrated that PKI-587 inhibited T-ALL cell line proliferation and colony formation via selective suppression of the PI3K/mTOR pathway without disturbing the mitogen-activated protein kinase (MAPK) pathway in vitro and in vivo.